Click for best price
Viral Vectors Gene Therapy Market Size, Share 2023
Viruses have evolved to become highly efficient at nucleic acid delivery to specific cell types while avoiding immunosurveillance by an infected host. These properties make viruses attractive gene-delivery vehicles, or vectors, for gene therapy. Several types of viruses, including retrovirus, adenovirus, adeno-associated virus (AAV), and herpes simplex virus, have been modified in the laboratory for use in gene therapy applications. Because these vector systems have unique advantages and limitations, each has applications for which it is best suited. Retroviral vectors can permanently integrate into the genome of the infected cell, but require mitotic cell division for transduction. Adenoviral vectors can efficiently deliver genes to a wide variety of dividing and nondividing cell types, but immune elimination of infected cells often limits gene expression in vivo.
This report aims to provide a comprehensive presentation of the global market for Viral Vectors Gene Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Viral Vectors Gene Therapy. This report contains market size and forecasts of Viral Vectors Gene Therapy in global, including the following market information:
Global Viral Vectors Gene Therapy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Viral Vectors Gene Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Retro Viral Vectors Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Viral Vectors Gene Therapy include Amgen, Novartis, Orchard Therapeutics, Spark Therapeutics, Agc Biologics, Anges, Bluebird Bio, Jazz Pharmaceuticals and Dynavax Technologies, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Viral Vectors Gene Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Viral Vectors Gene Therapy Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Viral Vectors Gene Therapy Market Segment Percentages, by Type, 2022 (%)
Retro Viral Vectors
Adeno-associated Virus Vectors
Other Viral Vectors
Global Viral Vectors Gene Therapy Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Viral Vectors Gene Therapy Market Segment Percentages, by Application, 2022 (%)
In Vivo
Ex Vivo
Global Viral Vectors Gene Therapy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Viral Vectors Gene Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Viral Vectors Gene Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Viral Vectors Gene Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Amgen
Novartis
Orchard Therapeutics
Spark Therapeutics
Agc Biologics
Anges
Bluebird Bio
Jazz Pharmaceuticals
Dynavax Technologies
Biogen
Sarepta Therapeutics
Gilead Sciences
Outline of Major Chapters:
Chapter 1: Introduces the definition of Viral Vectors Gene Therapy, market overview.
Chapter 2: Global Viral Vectors Gene Therapy market size in revenue.
Chapter 3: Detailed analysis of Viral Vectors Gene Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Viral Vectors Gene Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Viral Vectors Gene Therapy Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
68 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Viral Vectors Gene Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Viral Vectors Gene Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Viral Vectors Gene Therapy Overall Market Size
2.1 Global Viral Vectors Gene Therapy Market Size: 2022 VS 2029
2.2 Global Viral Vectors Gene Therapy Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Viral Vectors Gene Therapy Players in Global Market
3.2 Top Global Viral Vectors Gene Therapy Companies Ranked by Revenue
3.3 Global Viral Vectors Gene Therapy Revenue by Companies
3.4 Top 3 and Top 5 Viral Vectors Gene Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Viral Vectors Gene Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Viral Vectors Gene Therapy Players in Global Market
3.6.1 List of Global Tier 1 Viral Vectors Gene Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Viral Vectors Gene Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Viral Vectors Gene Therapy Market Size Markets, 2022 & 2029
4.1.2 Retro Viral Vectors
4.1.3 Adeno-associated Virus Vectors
4.1.4 Other Viral Vectors
4.2 By Type - Global Viral Vectors Gene Therapy Revenue & Forecasts
4.2.1 By Type - Global Viral Vectors Gene Therapy Revenue, 2018-2023
4.2.2 By Type - Global Viral Vectors Gene Therapy Revenue, 2024-2029
4.2.3 By Type - Global Viral Vectors Gene Therapy Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Viral Vectors Gene Therapy Market Size, 2022 & 2029
5.1.2 In Vivo
5.1.3 Ex Vivo
5.2 By Application - Global Viral Vectors Gene Therapy Revenue & Forecasts
5.2.1 By Application - Global Viral Vectors Gene Therapy Revenue, 2018-2023
5.2.2 By Application - Global Viral Vectors Gene Therapy Revenue, 2024-2029
5.2.3 By Application - Global Viral Vectors Gene Therapy Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Viral Vectors Gene Therapy Market Size, 2022 & 2029
6.2 By Region - Global Viral Vectors Gene Therapy Revenue & Forecasts
6.2.1 By Region - Global Viral Vectors Gene Therapy Revenue, 2018-2023
6.2.2 By Region - Global Viral Vectors Gene Therapy Revenue, 2024-2029
6.2.3 By Region - Global Viral Vectors Gene Therapy Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Viral Vectors Gene Therapy Revenue, 2018-2029
6.3.2 US Viral Vectors Gene Therapy Market Size, 2018-2029
6.3.3 Canada Viral Vectors Gene Therapy Market Size, 2018-2029
6.3.4 Mexico Viral Vectors Gene Therapy Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Viral Vectors Gene Therapy Revenue, 2018-2029
6.4.2 Germany Viral Vectors Gene Therapy Market Size, 2018-2029
6.4.3 France Viral Vectors Gene Therapy Market Size, 2018-2029
6.4.4 U.K. Viral Vectors Gene Therapy Market Size, 2018-2029
6.4.5 Italy Viral Vectors Gene Therapy Market Size, 2018-2029
6.4.6 Russia Viral Vectors Gene Therapy Market Size, 2018-2029
6.4.7 Nordic Countries Viral Vectors Gene Therapy Market Size, 2018-2029
6.4.8 Benelux Viral Vectors Gene Therapy Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Viral Vectors Gene Therapy Revenue, 2018-2029
6.5.2 China Viral Vectors Gene Therapy Market Size, 2018-2029
6.5.3 Japan Viral Vectors Gene Therapy Market Size, 2018-2029
6.5.4 South Korea Viral Vectors Gene Therapy Market Size, 2018-2029
6.5.5 Southeast Asia Viral Vectors Gene Therapy Market Size, 2018-2029
6.5.6 India Viral Vectors Gene Therapy Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Viral Vectors Gene Therapy Revenue, 2018-2029
6.6.2 Brazil Viral Vectors Gene Therapy Market Size, 2018-2029
6.6.3 Argentina Viral Vectors Gene Therapy Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Viral Vectors Gene Therapy Revenue, 2018-2029
6.7.2 Turkey Viral Vectors Gene Therapy Market Size, 2018-2029
6.7.3 Israel Viral Vectors Gene Therapy Market Size, 2018-2029
6.7.4 Saudi Arabia Viral Vectors Gene Therapy Market Size, 2018-2029
6.7.5 UAE Viral Vectors Gene Therapy Market Size, 2018-2029
7 Viral Vectors Gene Therapy Companies Profiles
7.1 Amgen
7.1.1 Amgen Company Summary
7.1.2 Amgen Business Overview
7.1.3 Amgen Viral Vectors Gene Therapy Major Product Offerings
7.1.4 Amgen Viral Vectors Gene Therapy Revenue in Global Market (2018-2023)
7.1.5 Amgen Key News & Latest Developments
7.2 Novartis
7.2.1 Novartis Company Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Viral Vectors Gene Therapy Major Product Offerings
7.2.4 Novartis Viral Vectors Gene Therapy Revenue in Global Market (2018-2023)
7.2.5 Novartis Key News & Latest Developments
7.3 Orchard Therapeutics
7.3.1 Orchard Therapeutics Company Summary
7.3.2 Orchard Therapeutics Business Overview
7.3.3 Orchard Therapeutics Viral Vectors Gene Therapy Major Product Offerings
7.3.4 Orchard Therapeutics Viral Vectors Gene Therapy Revenue in Global Market (2018-2023)
7.3.5 Orchard Therapeutics Key News & Latest Developments
7.4 Spark Therapeutics
7.4.1 Spark Therapeutics Company Summary
7.4.2 Spark Therapeutics Business Overview
7.4.3 Spark Therapeutics Viral Vectors Gene Therapy Major Product Offerings
7.4.4 Spark Therapeutics Viral Vectors Gene Therapy Revenue in Global Market (2018-2023)
7.4.5 Spark Therapeutics Key News & Latest Developments
7.5 Agc Biologics
7.5.1 Agc Biologics Company Summary
7.5.2 Agc Biologics Business Overview
7.5.3 Agc Biologics Viral Vectors Gene Therapy Major Product Offerings
7.5.4 Agc Biologics Viral Vectors Gene Therapy Revenue in Global Market (2018-2023)
7.5.5 Agc Biologics Key News & Latest Developments
7.6 Anges
7.6.1 Anges Company Summary
7.6.2 Anges Business Overview
7.6.3 Anges Viral Vectors Gene Therapy Major Product Offerings
7.6.4 Anges Viral Vectors Gene Therapy Revenue in Global Market (2018-2023)
7.6.5 Anges Key News & Latest Developments
7.7 Bluebird Bio
7.7.1 Bluebird Bio Company Summary
7.7.2 Bluebird Bio Business Overview
7.7.3 Bluebird Bio Viral Vectors Gene Therapy Major Product Offerings
7.7.4 Bluebird Bio Viral Vectors Gene Therapy Revenue in Global Market (2018-2023)
7.7.5 Bluebird Bio Key News & Latest Developments
7.8 Jazz Pharmaceuticals
7.8.1 Jazz Pharmaceuticals Company Summary
7.8.2 Jazz Pharmaceuticals Business Overview
7.8.3 Jazz Pharmaceuticals Viral Vectors Gene Therapy Major Product Offerings
7.8.4 Jazz Pharmaceuticals Viral Vectors Gene Therapy Revenue in Global Market (2018-2023)
7.8.5 Jazz Pharmaceuticals Key News & Latest Developments
7.9 Dynavax Technologies
7.9.1 Dynavax Technologies Company Summary
7.9.2 Dynavax Technologies Business Overview
7.9.3 Dynavax Technologies Viral Vectors Gene Therapy Major Product Offerings
7.9.4 Dynavax Technologies Viral Vectors Gene Therapy Revenue in Global Market (2018-2023)
7.9.5 Dynavax Technologies Key News & Latest Developments
7.10 Biogen
7.10.1 Biogen Company Summary
7.10.2 Biogen Business Overview
7.10.3 Biogen Viral Vectors Gene Therapy Major Product Offerings
7.10.4 Biogen Viral Vectors Gene Therapy Revenue in Global Market (2018-2023)
7.10.5 Biogen Key News & Latest Developments
7.11 Sarepta Therapeutics
7.11.1 Sarepta Therapeutics Company Summary
7.11.2 Sarepta Therapeutics Business Overview
7.11.3 Sarepta Therapeutics Viral Vectors Gene Therapy Major Product Offerings
7.11.4 Sarepta Therapeutics Viral Vectors Gene Therapy Revenue in Global Market (2018-2023)
7.11.5 Sarepta Therapeutics Key News & Latest Developments
7.12 Gilead Sciences
7.12.1 Gilead Sciences Company Summary
7.12.2 Gilead Sciences Business Overview
7.12.3 Gilead Sciences Viral Vectors Gene Therapy Major Product Offerings
7.12.4 Gilead Sciences Viral Vectors Gene Therapy Revenue in Global Market (2018-2023)
7.12.5 Gilead Sciences Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Viral Vectors Gene Therapy Market Opportunities & Trends in Global Market
Table 2. Viral Vectors Gene Therapy Market Drivers in Global Market
Table 3. Viral Vectors Gene Therapy Market Restraints in Global Market
Table 4. Key Players of Viral Vectors Gene Therapy in Global Market
Table 5. Top Viral Vectors Gene Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Viral Vectors Gene Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Viral Vectors Gene Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Viral Vectors Gene Therapy Product Type
Table 9. List of Global Tier 1 Viral Vectors Gene Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Viral Vectors Gene Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Viral Vectors Gene Therapy Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Viral Vectors Gene Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Viral Vectors Gene Therapy Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Viral Vectors Gene Therapy Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Viral Vectors Gene Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Viral Vectors Gene Therapy Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Viral Vectors Gene Therapy Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Viral Vectors Gene Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Viral Vectors Gene Therapy Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Viral Vectors Gene Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Viral Vectors Gene Therapy Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Viral Vectors Gene Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Viral Vectors Gene Therapy Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Viral Vectors Gene Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Viral Vectors Gene Therapy Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Viral Vectors Gene Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Viral Vectors Gene Therapy Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Viral Vectors Gene Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Viral Vectors Gene Therapy Revenue, (US$, Mn), 2024-2029
Table 30. Amgen Company Summary
Table 31. Amgen Viral Vectors Gene Therapy Product Offerings
Table 32. Amgen Viral Vectors Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 33. Amgen Key News & Latest Developments
Table 34. Novartis Company Summary
Table 35. Novartis Viral Vectors Gene Therapy Product Offerings
Table 36. Novartis Viral Vectors Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 37. Novartis Key News & Latest Developments
Table 38. Orchard Therapeutics Company Summary
Table 39. Orchard Therapeutics Viral Vectors Gene Therapy Product Offerings
Table 40. Orchard Therapeutics Viral Vectors Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 41. Orchard Therapeutics Key News & Latest Developments
Table 42. Spark Therapeutics Company Summary
Table 43. Spark Therapeutics Viral Vectors Gene Therapy Product Offerings
Table 44. Spark Therapeutics Viral Vectors Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 45. Spark Therapeutics Key News & Latest Developments
Table 46. Agc Biologics Company Summary
Table 47. Agc Biologics Viral Vectors Gene Therapy Product Offerings
Table 48. Agc Biologics Viral Vectors Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 49. Agc Biologics Key News & Latest Developments
Table 50. Anges Company Summary
Table 51. Anges Viral Vectors Gene Therapy Product Offerings
Table 52. Anges Viral Vectors Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 53. Anges Key News & Latest Developments
Table 54. Bluebird Bio Company Summary
Table 55. Bluebird Bio Viral Vectors Gene Therapy Product Offerings
Table 56. Bluebird Bio Viral Vectors Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 57. Bluebird Bio Key News & Latest Developments
Table 58. Jazz Pharmaceuticals Company Summary
Table 59. Jazz Pharmaceuticals Viral Vectors Gene Therapy Product Offerings
Table 60. Jazz Pharmaceuticals Viral Vectors Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 61. Jazz Pharmaceuticals Key News & Latest Developments
Table 62. Dynavax Technologies Company Summary
Table 63. Dynavax Technologies Viral Vectors Gene Therapy Product Offerings
Table 64. Dynavax Technologies Viral Vectors Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 65. Dynavax Technologies Key News & Latest Developments
Table 66. Biogen Company Summary
Table 67. Biogen Viral Vectors Gene Therapy Product Offerings
Table 68. Biogen Viral Vectors Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 69. Biogen Key News & Latest Developments
Table 70. Sarepta Therapeutics Company Summary
Table 71. Sarepta Therapeutics Viral Vectors Gene Therapy Product Offerings
Table 72. Sarepta Therapeutics Viral Vectors Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 73. Sarepta Therapeutics Key News & Latest Developments
Table 74. Gilead Sciences Company Summary
Table 75. Gilead Sciences Viral Vectors Gene Therapy Product Offerings
Table 76. Gilead Sciences Viral Vectors Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 77. Gilead Sciences Key News & Latest Developments
List of Figures
Figure 1. Viral Vectors Gene Therapy Segment by Type in 2022
Figure 2. Viral Vectors Gene Therapy Segment by Application in 2022
Figure 3. Global Viral Vectors Gene Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Viral Vectors Gene Therapy Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Viral Vectors Gene Therapy Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Viral Vectors Gene Therapy Revenue in 2022
Figure 8. By Type - Global Viral Vectors Gene Therapy Revenue Market Share, 2018-2029
Figure 9. By Application - Global Viral Vectors Gene Therapy Revenue Market Share, 2018-2029
Figure 10. By Type - Global Viral Vectors Gene Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Viral Vectors Gene Therapy Revenue Market Share, 2018-2029
Figure 12. By Application - Global Viral Vectors Gene Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Viral Vectors Gene Therapy Revenue Market Share, 2018-2029
Figure 14. By Region - Global Viral Vectors Gene Therapy Revenue Market Share, 2018-2029
Figure 15. By Country - North America Viral Vectors Gene Therapy Revenue Market Share, 2018-2029
Figure 16. US Viral Vectors Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Viral Vectors Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Viral Vectors Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Viral Vectors Gene Therapy Revenue Market Share, 2018-2029
Figure 20. Germany Viral Vectors Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 21. France Viral Vectors Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Viral Vectors Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Viral Vectors Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Viral Vectors Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Viral Vectors Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Viral Vectors Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Viral Vectors Gene Therapy Revenue Market Share, 2018-2029
Figure 28. China Viral Vectors Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Viral Vectors Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Viral Vectors Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Viral Vectors Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 32. India Viral Vectors Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Viral Vectors Gene Therapy Revenue Market Share, 2018-2029
Figure 34. Brazil Viral Vectors Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Viral Vectors Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Viral Vectors Gene Therapy Revenue Market Share, 2018-2029
Figure 37. Turkey Viral Vectors Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Viral Vectors Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Viral Vectors Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Viral Vectors Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 41. Amgen Viral Vectors Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Novartis Viral Vectors Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Orchard Therapeutics Viral Vectors Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Spark Therapeutics Viral Vectors Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Agc Biologics Viral Vectors Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Anges Viral Vectors Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Bluebird Bio Viral Vectors Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Jazz Pharmaceuticals Viral Vectors Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Dynavax Technologies Viral Vectors Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Biogen Viral Vectors Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Sarepta Therapeutics Viral Vectors Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Gilead Sciences Viral Vectors Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
